Article
[Pharmacogenetic approaches to predicting the efficiency and safety of amlodipine in patients with arterial hypertension].
Biomeditsinskaia khimiia - 1 Oct 2017
Sychev D A, Shih N V, Kalle E G, Ryzhikova K A, Morozova T E
Abstract excerpt
An open, non-comparative, prospective clinical study was conducted to evaluate the antihypertensive efficacy and tolerability of amlodipine, a calcium antagonist, in patients with arterial hypertension (AH) I-II stages, depending on the genotype for the polymorphic marker C3435T of the ABCB1 gene. The study included 100 patients with AH I-II stages, aged from 45 to 58 years. The initial dose of amlodipine was 5...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
